Skip to content
Company Analysis

Agilent Technologies, Inc. A

A comprehensive view of key metrics, scores, and financial health for Agilent Technologies, Inc.

Overview of Agilent Technologies, Inc.

A NYQ
Healthcare Diagnostics & Research Framework: Medical Devices & Diagnostics Large Cap
Agilent Technologies, Inc. (A), is a Large Cap company, in the Diagnostics & Research industry, last closed at $129.84, about 66.6% overvalued vs fair value, +9.1% 1Y return, placing in the top 10% of its sector.
Metrics Rev Growth 6.7% ROE 20.6% Gross Margin 52.4% Div Yield 0.68%
USD 129.84
0.22%
(Delayed)
• Vol 90d: 39.1%
52-Week Range
Market Cap
$37.17B
Enterprise Value
$38.77B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Excellent
Health
Fair
Efficiency
Weak
Valuation
Good
Growth
Fair
Profitability
Excellent
Health
Fair
Efficiency
Weak
Valuation
Good
Completeness: 82%
Confidence: 89%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://www.agilent.com
HQ Santa Clara, CA
Employees 18,000
Fiscal year Oct 31

Next Events

Dividend Jul 22 Ex-div: Jun 30
Earnings Aug 26 Estimated

Fair Value Snapshot

Bear Base Bull
$39
$43
$48
Current: $129.84 -67% vs base

Engine Room Money Flow™

Large Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
6.51B
6.7%%
Gross Profit
3.54B
3.1%%
Operating Income (GAAP)
1.49B
-0.6%%
EBITDA
1.87B
-2.1%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
52.4%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$707.0M
61.4% of Free Cash Flow

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
1
Active Leaks
0/1
Improving
0
High Impact
0
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Agilent Technologies, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
69
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
60
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 100% Coverage
Trade-Off Triangle Visualization A ternary plot showing A's balance between Growth (23.4%), Profitability (44.1%), and Safety (32.5%). Growth 23% Safety 33% Profitability 44%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

45th percentile vs peers
46
Key Signals
Rev Growth YoY 6.7% 52p EPS CAGR 3Y 4.0% 54p Revenue CAGR 3Y 0.5% 32p EPS Growth YoY 5.7% 36p TSR 13.1% 62p
Strengths
  • Interest Coverage Ratio in top 20% of peers (13.81, 84th percentile)
  • Superior capital returns - 3 return metrics above peer median
  • Operating Margin in top 20% of peers (21.3%, 92th percentile)
Risks

No significant risks identified for this axis.

Profitability

85th percentile vs peers
86
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

63th percentile vs peers
63
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Agilent Technologies, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$43.32
- - -
-66.6% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000